Dermatology Diagnostic Devices and Therapeutics Market

Dermatology Diagnostic Devices and Therapeutics
Market Trends, Outlook, and Opportunity Analysis,
2018-2026
Dermatology is the branch of science, which deals with skin and its appendages such as nails,
hairs, sweet glands, and among others. Primary skin care and skin hygiene is the major concern
of urbanization. Polluted environment leads to number of skin allergies and trigger various
chronic diseases such as skin cancer. According to a study by Clinical Dermatology, in 2013,
approximately 25% of the population suffers from skin ailments globally, out of which 15% of
the population consult general physician with skin problem, wherein 1.2% refer to the
dermatologist while rest are left unattended. It has also been stated that skin conditions are the
fourth leading cause of nonfatal disease burden. Dermatology diagnostic devices and
therapeutics market is the most dynamic and competitive market and is projected to retain
same in the near future.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/933
Rising prevalence of skin ailments and its impact is fueling the market growth
Dermatology diagnostic devices and therapeutic market is expected to increase, due to high
prevalence of skin problem such as fungal infections, scabies, acne, psoriasis, and atopic
eczema. According to a study by Global Burden of Disease (GBD), in 2010, fungal skin disease,
subcutaneous disease, and acne are ranked among the top ten most prevalent diseases
worldwide. The trajectory of the market depends on the rise of pollutants in the environment,
drug patent expiry, over use of cosmetics, prevalence of chronic diseases, and increasing pool of
children affected with skin ailments. Rising awareness about skin ailments and its treatment is a
key factor augmenting the dermatology diagnostic device and therapeutic market growth. New
and improved dermatology diagnostics products, for instance, in 2016 Sun Pharmaceutical
Industries Ltd launched Suncros, a highly efficient product for all skin ailments, contributed
largely towards the market growth.
Regional Insight of the dermatology diagnostic devices and therapeutics market
Geographically, 33.2 % population of North America have significant skin ailments that deserve
medical attention. According to the Journal of the American Academy of Dermatology, around
50 million people were affected with acne in North America in 2010, out of which 85% aged
between 12 and 24, accounting to higher ratio in young population. In 2017, Food and Drug
Administration (FDA) has approved a new product named Dupixent, which is used to treat
atopic dermatitis, expected to propel the market growth in this region. According to a report by
European Dermato-Epidemiology, in 2014, approximately 19% of the adults and 14% of children
have skin diseases that need to be attended in Europe. This is mainly owing to high prevalence
and high awareness of skin ailments, well-organized healthcare services, and reimbursement
policies.
Report includes chapters which deeply display the following deliverable about industry :
• Dermatology Diagnostic Devices and Therapeutics Market Research Objective and Assumption
• Dermatology Diagnostic Devices and Therapeutics Market Purview - Report Description,
Executive Summary, and Coherent Opportunity Map (COM)
• Dermatology Diagnostic Devices and Therapeutics Market Dynamics, Regulations, and Trends
Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New
system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Dermatology Diagnostic Devices and Therapeutics Market, By Regions
• Dermatology Diagnostic Devices and Therapeutics Market Competition by Manufacturers
including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales
Area and Product Type.
• Dermatology Diagnostic Devices and Therapeutics Market Manufacturers Profiles/Analysis
including Company Basic Information, Manufacturing Base and Its Competitors.
• Dermatology Diagnostic Devices and Therapeutics Market Manufacturing Cost Analysis
including Key Raw Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Dermatology Diagnostic Devices and Therapeutics Market Forecast including Production,
Consumption, Import and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Latest launch and improved products is driving the Dermatology diagnostic devices and
therapeutics market growth
Innovation of new and improved products in the market is expected to keep the market more
competitive to combat with the latest product. For example, new product Dupixent approved by
the U.S. FDA in 2017, is an injectable medication for the adult patients with moderate or acute
eczema. This is mainly for the patients affected by the disease which cannot be controlled with
prescription therapies used on skin (topically). Some of the major players operating in the
global dermatology diagnostic devices and therapeutics market include Agfa-Gevaert N.V.,
Valeant Pharmaceuticals International, Inc., Cutera, Inc., Astellas Pharma, Inc., Galderma S.A.,
Novartis International AG., Dino-Lite Europe/IDCP B.V., Genentech, LEO Pharma A/S, Michelson
Diagnostics Ltd, and Sun Pharmaceutical Industries Ltd.
Ask For Discount Before Purchasing This Business Report @
https://www.coherentmarketinsights.com/insight/request-discount/933
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Dermatology is the branch of science, which deals with skin and its appendages such as nails, hairs, sweet glands, and among others.